Anti-amnesic effect of alkaloid fraction from Lycopodiella cernua (L.) Pic. Serm. on scopolamine-induced memory impairment in mice

Neuroscience Letters

Volumn 575, Issue , 2014, Pages 42-46

  Chuong, Nguyen Ngoc ^a   Trung, Bui Huu ^b   Luan, Tran Cong ^a   Hung, Tran Manh ^b,c   Dang, Nguyen Hai ^d   Dat, Nguyen Tien ^d  

^a Research Center of Ginseng and Medicinal Materials   (Viet Nam)

^b UNIVERSITY OF NATURAL SCIENCES   (Viet Nam)

^c Catholic University of Daegu   (South Korea)

^d GRADUATE UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Viet Nam)

Author keywords

Acetylcholinesterase; Amnesic; Licopodiaceae; Lycopodiella cernua; Scopolamine

Indexed keywords

ACETYLCHOLINESTERASE; ALKALOID DERIVATIVE; BERBERINE; CHOLINESTERASE INHIBITOR; LYCOPODIELLA CERNUA ALKALOID FRACTION; PLANT EXTRACT; SCOPOLAMINE; TACRINE; UNCLASSIFIED DRUG; ALKALOID; METHANOL; NOOTROPIC AGENT; SCOPOLAMINE BROMIDE; SOLVENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CHOLINERGIC TRANSMISSION; CHOLINESTERASE INHIBITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; FOOTSHOCK; FRONTAL CORTEX; HIPPOCAMPUS; IC 50; IN VITRO STUDY; IN VIVO STUDY; LONG TERM MEMORY; LYCOPODIACEAE; LYCOPODIELLA CERNUA; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; SCOPOLAMINE-INDUCED AMNESIA; TRADITIONAL MEDICINE; ANIMAL; AVOIDANCE BEHAVIOR; BRAIN; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; ISOLATION AND PURIFICATION; MALE; MAZE TEST; MEMORY DISORDERS; METABOLISM; PSYCHOLOGY; SPRAGUE DAWLEY RAT; VIET NAM;

ACETYLCHOLINESTERASE; ALKALOIDS; ANIMALS; AVOIDANCE LEARNING; BRAIN; CHOLINESTERASE INHIBITORS; LYCOPODIACEAE; MALE; MAZE LEARNING; MEMORY DISORDERS; METHANOL; NOOTROPIC AGENTS; PLANT EXTRACTS; RATS, SPRAGUE-DAWLEY; SCOPOLAMINE HYDROBROMIDE; SOLVENTS; VIETNAM;

EID: 84901940892     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.05.031     Document Type: Article

References (24)

1. Becker R., Giacobini E., Elble R., McIlhany M., Sherman K. Potential pharmacotherapy of Alzheimer disease. A comparison of various forms of physostigmine administration. Acta Neurol. Scand. Suppl. 1988, 116:19-32.
2. Giacobini E. Cholinesterase Inhibitors: From the Calabar Bean to Alzheimer Therapy 2000, 181-226. M. Dunitz, Thonex, Geneva. E. Giacobini (Ed.).
3. Oh M.H., Houghton P.J., Whang W.K., Cho J.H. Screening of Korean herbal medicines used to improve cognitive function for anti-cholinesterase activity. Phytomedicine 2004, 11:544-548.
4. Houghton P.J., Ren Y., Howes M.J. Acetylcholinesterase inhibitors from plants and fungi. Nat. Prod. Rep. 2006, 23:181-199.
5. Ma X., Tan C., Zhu D., Gang D.R., Xiao P. Huperzine A from Huperzia species-an ethnopharmacolgical review. J. Ethnopharmacol. 2007, 113:15-34.
6. Liu J.S., Zhu Y.L., Yu C.M., Zhou Y.Z., Han Y.Y., Wu F.W., Qi B.F. The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity. Can. J. Chem. 1986, 64:837-839.
7. Ma X., Gang D.R. The lycopodium alkaloids. Nat. Prod. Rep. 2004, 21:752-772.
8. Zhang R.W., Tang X.C., Han Y.Y., Sang G.W., Zhang Y.D., Ma Y.X., Zhang C.L., Yang R.M. Drug evaluation of huperzine A in the treatment of senile memory disorders. Zhongguo Yao Li Xue Bao 1991, 12:250-252.
9. Ortega M.G., Agnese A.M., Cabrera J.L. Anticholinesterase activity in an alkaloid extract of Huperzia saururus. Phytomedicine 2004, 11:539-543.
10. Vallejo M.G., Ortega M.G., Cabrera J.L., Carlini V.P., Rubiales de Barioglio S., Agnese A.M. Huperzia saururus increases memory retention in rats. J. Ethnopharmacol. 2007, 111:685-687.
11. Konrath E.L., Neves B.M., Passos C.S., Lunardi P.S., Ortega M.G., Cabrera J.L., Gonçalves C.A., Henriques A.T. Huperzia quadrifariata and Huperzia reflexa alkaloids inhibit acetylcholinesterase activity in vivo in mice brain. Phytomedicine 2012, 19:1321-1324.
12. Calderón A.I., Simithy-Williams J., Sanchez R., Espinosa A., Valdespino I., Gupta M.P. Lycopodiaceae from Panama: a new source of acetylcholinesterase inhibitors. Nat. Prod. Res. 2013, 27:500-505.
13. Lim W.H., Goodger J.Q., Field A.R., Holtum J.A., Woodrow I.E. Huperzine alkaloids from Australasian and southeast Asian Huperzia. Pharm. Biol. 2010, 48:1073-1078.
14. Ho R., Marsousi N., Eugster P., Bianchini J.P., Raharivelomanana P. Detection by UPLC/ESI-TOF-MS of alkaloids in three Lycopodiaceae species from French Polynesia and their anticholinesterase activity. Nat. Prod. Commun. 2009, 4:1349-1352.
15. Halldorsdottir E.S., Jaroszewski J.W., Olafsdottir E.S. Acetylcholinesterase inhibitory activity of lycopodane-type alkaloids from the Icelandic Lycopodium annotinum ssp. Alpestre. Phytochemistry 2010, 71:149-157.
16. Ho P.H. Cay Co Viet Nam: An Illustrated Flora of Viet Nam 1999, 2:24. Nha Xuat Ban Tre, Hanoi.
17. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961, 7:88-90.
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
19. Hung T.M., Na M., Dat N.T., Ngoc T.M., Youn U., Kim H.J., Min B.S., Lee J., Bae K. Cholinesterase inhibitory and anti-amnesic activity of alkaloids from Corydalis turtschaninovii. J. Ethnopharmacol. 2008, 119:74-80.
20. Zhao Q., Tang X.C. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine. Eur. J. Pharmacol. 2002, 455:101-107.
21. Giacobini E. The cholinergic system in Alzheimer disease. Prog. Brain Res. 1990, 84:321-332.
22. LeDoux J.E. Emotional memory systems in the brain. Behav. Brain Res. 1993, 58:69-79.
23. Izzo A.A., Capasso F. Herbal medicines to treat Alzheimer's disease. Trends Pharmacol. Sci. 2007, 28:47-48.
24. Ebert U., Kirch W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur. J. Clin. Invest. 1998, 28:944-949.